Tocilizumab for Relapsing and Remitting Giant Cell Arteritis Tocilizumab for Relapsing and Remitting Giant Cell Arteritis

This case series highlights the development and delivery of an effective hub and referral pathway for the use of tocilizumab in patients with refractory or relapsing giant cell arteritis.Journal of Medical Case Reports

Source: Medscape Today Headlines - November 14, 2022 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news